Clinical Trials Logo

Filter by:
NCT ID: NCT05715632 Recruiting - Gastric Cancer Clinical Trials

New Adjuvant Treatment of Locally Advanced Resectable Gastric Cancer With Carelizumab and XELOX

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

To evaluate the efficacy and safety of carelizumab combined with XELOX regimen in neoadjuvant treatment of locally advanced resectable gastric cancer

NCT ID: NCT05715606 Recruiting - Clinical trials for Diffuse Large B-cell Lymphoma

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of r/r DLBCL Clinical Research

Start date: February 10, 2023
Phase: Early Phase 1
Study type: Interventional

A Study of Metabolically Armed CD19 CAR-T Cells Therapy for Patients With Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma

NCT ID: NCT05715424 Recruiting - Myopia Clinical Trials

Community Intervention and Demonstration Area Construction

Start date: December 1, 2022
Phase: N/A
Study type: Interventional

The objective of this intervention study was to understand the visual health status of nearly one million children and adolescents in ten provinces in China, and then to conduct intervention and evaluate the effect of intervention measures with the development of myopia as the outcome indicator. The study will be conducted in the form of a stepped intervention and will answer the following questions. Current China children and adolescent's vision health, including the different degrees of myopia prevalence, and farsightedness reserve status. To evaluate the implementation and effect of eight appropriate technologies and six interventions developed in this study, to reduce the incidence of myopia among children and adolescents in China, to achieve the purpose of nationwide application. In the early stage of this study, a baseline survey will be conducted on participants. In the middle stage, participants will be required to adjust the seat height regularly and increase the time for outdoor activities, etc. In the later stage, intervention measures will be evaluated based on the overall research situation to consider national promotion.

NCT ID: NCT05715333 Recruiting - Healthy Clinical Trials

Study of CM326 Injection in Healthy Subjects

Start date: March 21, 2023
Phase: Phase 1
Study type: Interventional

This study is a single-center, randomized, double-blind, placebo-controlled, dose-increasing phase I clinical study.

NCT ID: NCT05715320 Recruiting - Atopic Dermatitis Clinical Trials

Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis

Start date: March 10, 2023
Phase: Phase 2
Study type: Interventional

This study is a multi-center, randomized, double-blind, parallel controlled phase 2 study, aimed at evaluating the efficacy and safety of CM310 in the treatment of patients with moderate-to-severe atopic dermatitis, and observing Pharmacokinetics characteristics, Pharmacodynamics effects and immunogenicity.

NCT ID: NCT05715307 Recruiting - Type 2 Diabetes Clinical Trials

Chinese Endocrinologists Health Education Study

CREATION
Start date: February 9, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct a prospective, multicenter, cluster randomized control study, evaluating the improvement for T2DM diagnosis and treatment ability in Chinese endocrinologists after 1-week intensive experiential diabetes management training in the leading center.

NCT ID: NCT05715138 Not yet recruiting - Cervical Dystonia Clinical Trials

Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Cervical dystonia (CD), also known as spasmodic torticollis, is a type of focal dystonia, mainly manifesting as involuntary head turning or tilting, or holding a twisted posture. Although it can be alleviated by injection of botulinum toxin, the effect is temporary so that patients require multiple injections. Deep Brain Stimulation (DBS) targeting on globus pallidus internus (GPi) or subthalamic nucleus (STN) has been proved to be a safe and effective strategy for primary cervical dystonia, even for those medically refractory cases. However, the question of which target is better has not been clarified. Therefore, the invstigators design this randomized and controlled trial, aiming to compare the differences between GPi-DBS and STN-DBS for cervical dystonia in the improvement of symptoms , quality of life, mental status, cognitive status, as well as in stimulation parameters and adverse effects. The invstigators hypothesize that STN-DBS will outperform GPi-DBS at short-term follow-up, while the superiority will disappear and the efficacy of the two group will become similar at long-term follow-up.

NCT ID: NCT05714904 Recruiting - Clinical trials for Bietti's Crystalline Dystrophy

Safety and Tolerability of ZVS101e in Patients With Bietti 's Crystalline Dystrophy

Start date: September 23, 2022
Phase: Early Phase 1
Study type: Interventional

The purpose of the study is to evaluate the safety and tolerability of an adeno-associated virus vector expressing CYP4V2 in patients with Bietti's crystalline dystrophy (BCD).

NCT ID: NCT05714878 Completed - Stomach Neoplasm Clinical Trials

Multimodal Prehabilitation for Resectable Gastric Cancer

Start date: March 22, 2023
Phase: N/A
Study type: Interventional

Surgical resection is the mainstay for gastric cancer. Surgical stress response, like insulin resistance and catabolism, is inevitable and is a risk factor for postoperative outcome. To cope with this stress, the enhanced recovery protocol has been proposed and successfully implemented in clinical practice. Recently, prehabilitation have attracted increasingly attention, which is the preoperative part of enhanced recovery pathway. Prehabtilitation are bundles of evidenced elements in order to improve patient's functional capacity. Patients with gastric cancer are usually suffered from nutritional risk, anxiety and frailty. In this trial, we investigate whether multimodal prehabilitation (exercise, nutrition and psychological support) could improve patient's functional status to better tolerate surgical trauma.

NCT ID: NCT05714748 Recruiting - Malignant Tumors Clinical Trials

Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors

Start date: November 18, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of mRNA vaccine for the EBV-positive Advanced Malignant Tumors.